When you first look at a peptide Certificate of Analysis, it can feel like reading a different language.
HPLC. LC-MS. LAL. Chromatogram. Endotoxin. Molecular mass. Purity by area percentage.
These terms matter, but they are not always explained clearly. A lot of suppliers show a COA and assume the buyer already knows what everything means. We do not think that is good enough.
At Precision Synthetics Canada, we want research buyers to understand the documentation they are reviewing before they place an order. A COA should not feel like a mystery document. It should help you understand what was tested, what the result actually means, and what the test does not prove.
The simplest way to think about it is this: HPLC helps review purity, LC-MS helps support identity, and LAL helps screen for bacterial endotoxins.
They are related, but they do not answer the same question.
Why One Test Cannot Tell the Whole Story
It is tempting to look for one number that explains everything. In peptide research supply, that number is usually purity percentage.
A high purity result can be reassuring, but it does not answer every quality-control question. Purity is not the same as identity. Identity is not the same as endotoxin screening. Endotoxin screening is not the same as sterility. Each test gives researchers a different piece of the documentation picture.
That is why a stronger COA is not just about showing one impressive number. It is about showing the right testing records together, so the buyer can review the batch from more than one angle.
Think of it like checking a passport at the airport. One person checks that the photo matches the traveller. Another checks that the document is valid. Another checks the baggage. Each step answers a different question. No single check replaces all the others.
COA testing works in a similar way. HPLC, LC-MS, and LAL each have their own role.
What HPLC Actually Tells You
HPLC stands for High-Performance Liquid Chromatography.
That sounds technical, but the basic idea is simple. HPLC is a lab method that separates the different components in a sample so the lab can see what is present and how much of the detected material appears to be the main compound.
Imagine pouring a mixed bag of beads onto a sorting tray. The tray separates the beads by certain properties, so you can see the main bead type and any smaller groups mixed in. HPLC does something similar, except it is separating molecules instead of beads.
The result is shown on a graph called a chromatogram. On that graph, the main compound usually appears as the largest peak. Smaller peaks may represent related impurities, byproducts, or other detected components. The purity percentage is commonly calculated by comparing the area of the main peak against the total detected peak area.
In plain English, HPLC helps answer this question:
How much of the detected sample appears to be the main compound?
That is why HPLC is so commonly associated with peptide purity. It is useful because it gives researchers a way to review the purity profile of a sample instead of relying only on a claim written on a product page.
But HPLC still has limits. A purity result can look strong, but researchers should still ask whether the COA includes supporting details. Is there a chromatogram? Is there a testing date? Is there a batch or lot connection? Is the compound name clear? Does the report show enough information to understand how the result was reached?
A purity number is more meaningful when the supporting data is visible.
What LC-MS Actually Tells You
LC-MS stands for Liquid Chromatography-Mass Spectrometry.
The name sounds intimidating, but the purpose is easier to understand than the term itself. LC-MS helps support identity by looking at the molecule’s mass.
One way to think about it is like checking whether a key has the right shape and weight for a specific lock. If the measured molecular mass lines up with the expected mass of the peptide, that supports the idea that the material is the compound it claims to be.
This matters because purity and identity are not the same thing.
HPLC can help show how clean the sample looks under that testing method, but LC-MS helps answer a different question:
Does the molecule appear to match the expected compound?
That distinction is important. A COA that only shows purity may still leave unanswered questions about identity. A stronger documentation set should help researchers review both purity and identity, not just one or the other.
For peptide materials, LC-MS or mass spectrometry data can be especially useful because peptides have expected molecular weights. When the observed result lines up with the expected molecular mass, it gives researchers another layer of confidence that the material being reviewed matches the stated compound.
That does not mean LC-MS magically proves everything about a product. It does not replace batch traceability, handling review, endotoxin screening, or proper research judgment. But it is an important identity-supporting tool, and it makes a COA more meaningful than a purity percentage alone.
What LAL Actually Tells You
LAL stands for Limulus Amebocyte Lysate.
This is probably the least familiar term for many buyers, but it is an important one. LAL testing is used to screen for bacterial endotoxins.
Endotoxins are substances associated with certain bacteria. They are not the same thing as ordinary impurities shown in an HPLC purity report. That is why endotoxin screening needs its own testing method.
In plain English, LAL helps answer this question:
Was bacterial endotoxin detected under the method and limits used by the testing laboratory?
This is different from asking whether the peptide is pure. It is also different from asking whether the peptide identity is correct.
A sample could have a strong HPLC purity result and still need separate endotoxin screening if that information matters for the research documentation being reviewed. That is why we consider LAL endotoxin testing a useful additional data point. It looks at a different concern than HPLC or LC-MS.
It is also important to be clear about what LAL testing does not mean.
LAL testing does not make a product sterile. It does not mean a product is injectable. It does not mean a product is approved for human or veterinary use. It does not replace sterility testing. It is not dosing guidance, safety guidance, or a therapeutic claim.
For our purposes, LAL endotoxin screening is part of a research documentation model. It gives buyers another piece of information to review for supported batches, but it does not change the research-use-only status of the material.
The Easy Way to Remember the Difference
A simple way to remember the difference is to think of each test as asking a different question.
HPLC asks, “How pure does the sample look under this method?”
LC-MS asks, “Does the molecule appear to match the expected identity?”
LAL asks, “Is bacterial endotoxin detected under this testing method?”
That is why these tests are strongest when they are viewed together. Each one fills in a different part of the picture.
HPLC gives researchers a purity profile. LC-MS gives identity-supporting information. LAL gives endotoxin screening information. None of them should be treated as a substitute for the others.
This is also why we do not believe a COA should be judged only by the largest number on the page. A 99% purity claim may look impressive, but serious review should go deeper. Researchers should look at what type of testing was performed, whether the report is batch-linked, whether the results are supported by visible data, and whether additional testing is available.
The more complete the documentation, the easier it is to evaluate the batch responsibly.
Why This Matters When Reviewing a Peptide COA
A COA is only useful if the buyer understands what it is actually showing.
If a report shows HPLC purity, that is useful for reviewing the purity profile. If a report includes LC-MS or mass spectrometry data, that helps support identity. If a report includes LAL endotoxin screening, that adds another quality-control data point. If the report is batch-linked, it becomes easier to connect the documentation to the actual product being considered.
This is the difference between simply posting a COA and building a more transparent documentation system.
At Precision Synthetics Canada, our current testing model supports source-lab third-party analysis as well as our own separate third-party analysis, including LAL endotoxin testing where supported. The goal is not to overwhelm buyers with technical language. The goal is to give research buyers more to review before they place an order.
We believe that matters because trust should not come from a product description alone. It should come from documentation that is visible, understandable, and connected to the batch.
Why We Explain These Terms Clearly
The research peptide space can be confusing. Many websites use the same phrases. Many product pages highlight purity percentages. Many buyers are left trying to compare suppliers without knowing what the testing terms actually mean.
We want to make that process easier.
If you are reviewing a COA, you should not need to be a chemist to understand the basic purpose of each test. You should be able to tell whether the report is showing purity, identity, endotoxin screening, or something else entirely.
That is why we try to explain these terms in plain language. Technical documentation should still be accurate, but it should not be needlessly confusing. A buyer should be able to look at a COA and understand the role each test plays in the larger review process.
When testing information is clear, researchers can make more informed decisions. When documentation is vague, cropped, disconnected, or reduced to a single purity number, buyers are left guessing.
We do not think buyers should have to guess.
Our View: Better Testing Context Builds Better Trust
HPLC, LC-MS, and LAL are not just technical acronyms. They represent different ways of asking important quality-control questions.
HPLC helps review purity. LC-MS helps support identity. LAL helps screen for bacterial endotoxins. Together, they give researchers a clearer picture than any single test can provide on its own.
That is why we believe COA transparency should go beyond a headline purity percentage. A strong documentation model should help buyers understand what was tested, how the results should be interpreted, and what the limitations are.
For available batch documentation, visit our COA library. If you want a deeper walkthrough of common COA fields, chromatograms, identity data, endotoxin results, and red flags, read our guide on how to read a peptide COA.
At the end of the day, a COA should do more than look official.
It should help you understand what you are reviewing.
Research-use notice: Precision Synthetics Canada products and documentation are provided strictly for lawful, non-clinical laboratory research purposes only. COAs and testing records are not medical documents, safety guarantees, sterility guarantees, therapeutic endorsements, dosing guidance, or approval for human or veterinary use.